Skip to content

PHARMACEUTICAL PRODUCTS

DRY POWDER INHALER AND NEBULIZER APPLICATIONS

Accelerate your product development and approvals by providing the information necessary for predictive clinical outcomes and bioequivalence.

Our new INVIDA™ Platform lets you measure the aerosol dispersion and regional deposition of inhaled drugs under human-realistic breathing profiles. A valuable tool for understanding your product’s in vivo performance, the innovative technology gives you a visual map of your product within the respiratory tract, as well as quantitative measurements of drug deposition. Applications include:

  • Predictive Clinical Assessment
  • Bioequivalence – IVIVC Studies
  • Dispersion & Deposition Studies
  • Formulation Characterization & Screening
  • Particle Flight - Dispersion - Deposition Characterization
  • Device Characterization, Design & Screening
  • Peak Inspiratory Flow Studies
  • Total Delivered Dose Content
  • Device Resistance Characterization
*NEW APPLICATION

Determine true product performance and enable predictive in vivo correlation.

Let our experts help unlock the complex relationship between formulation, device, and human usage.